Health
Experimental drug combination extends survival in mice with lung cancer, study finds – News-Medical.Net
A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival…
A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.
Led by researchers at NYU Grossman School of Medicine and its Laura and Isaac Perlmutter Cancer…
Continue Reading
-
Business18 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News18 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business14 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News17 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses